.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Express Scripts
McKesson
McKinsey
Cerilliant
Cantor Fitzgerald
Medtronic
Fish and Richardson
Mallinckrodt

Generated: September 22, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation
Abstract:The present invention relates to products of the formula ##STR1## where R.sub.1 is H or alkyl, n is an integer from 0 to 10, and R.sub.2 is chosen from amongst H, unsubstituted or substituted alkyl radicals, a ##STR2## group, a substituted or unsubstituted phenyl radical, a ##STR3## group, where X is oxygen or sulfur, or a heterocyclic radical with 5 or 6 members, which may or may not be fused to a benzene ring and R.sub.3 is H or OH. The present invention also relates to a process for the preparation of the products of the formula (I), and to the drugs, having in particular an anti-inflammatory effect, containing a product of formula (I).
Inventor(s): Breliere; Jean C. (Montpellier, FR), Emonds-Alt; Xavier (Montpellier, FR), Garcia; Georges (Saint-Gely-du-Fesc, FR)
Assignee: Sanofi (Paris, FR)
Application Number:07/165,080
Patent Claims: 1. A methylene-diphosphonic acid compound having the formula: ##STR56## in which: R.sub.1 is hydrogen or a straight or branched lower alkyl group having from 1 to 4 carbon atoms,

R.sub.2 is a phenyl group which is or substituted one or more times by halogen, a nitro group, a lower alkyl group, a lower alkoxy group, trifluoromethyl, an NH.sub.2 group, a COOH group;

R.sub.3 is hydrogen or a hydroxyl group; and

n is an integer between 0 and 10, with the proviso that n cannot be 0 if R.sub.3 is OH, and with the further proviso that:

R.sub.2 is different from the group having the formula ##STR57## wherein Q is a halogen atom, a nitro group or a trifluoromethyl group and T is methyl, ethyl or butyl when R.sub.1 is a methyl or ethyl group, R.sub.3 is hydrogen and n=0;

and the salts of said compounds with inorganic or organic bases when R.sub.1 =H.

2. A methylene-disphosphonic acid compound according to claim 1, having the formula (I) in which n=0 and ##STR58## R.sub.3 =H, and the salts of said compounds with inorganic or organic bases when R.sub.1 =H.

3. A methylene-disphosphonic acid compound according to claim 1, having the formula: ##STR59## or one of its salts with inorganic or organic bases.

4. Pharmaceutical compositions which contain in association with a pharmaceutically acceptable carrier an effective amount of a compound of formula (I): ##STR60## in which: R.sub.1 is hydrogen or a straight or branched lower alkyl group having from 1 to 4 carbon atoms

R.sub.2 is a phenyl group which is or substituted one or more times by halogen, a nitro group, a lower alkyl group, a lower alkoxy group, trifluoromethyl, an NH.sub.2 group, a COOH group;

R.sub.3 is hydrogen or a hydroxyl group; and

n is an integer between 0 and 10, with the proviso that n cannot be 0 if R.sub.3 is OH;

or of one of its salts with inorganic or organic bases when R.sub.1 =H.

5. A pharmaceutical composition according to claim 4, which contains from 10 to 500 mg of the compound of formula I as an active ingredient.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Cantor Fitzgerald
Teva
Queensland Health
Novartis
Citi
Federal Trade Commission
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot